Bharat Biotech, which partnered with the Indian Council of Medical Research and National Institute of Virology to develop Covaxin, was the fourth pharmaceutical firm to apply for EUA in the country.
Full Post on Source: Indian firm seeks emergency use approval for COVID-19 vaccine in Philippines
